Clincosm LogoSign in Get a demo

A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province

Sponsor
Xijing Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04235192
Collaborator
First Affiliated Hospital Xi'an Jiaotong University (Other), Shaanxi Provincial People's Hospital (Other), Xi'an No.3 Hospital (Other), Shaanxi Armed Police Corps Hospital (Other), Northwest Women's and Children's Hospital, Xi'an, Shaanxi (Other)
1,340
Enrollment
1
Location
14.1
Anticipated Duration (Months)
95.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Through a multicenter case-control study on the risk factors of premature ejaculation in Shaanxi, to find out the related factors of the occurrence and development of premature ejaculation, to provide reference for personalized treatment, in order to improve the quality of sexual life of patients and partners.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1340 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province
    Actual Study Start Date :
    Jul 31, 2019
    Anticipated Primary Completion Date :
    Aug 31, 2020
    Anticipated Study Completion Date :
    Oct 1, 2020

    Outcome Measures

    Primary Outcome Measures

    1. IELT [Within 6 months]

      Intra-vaginal Ejaculation Latency Time

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 64 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
      1. case group

    1. 18-64 years old, regular sexual life > 6 months;

    2. Self-report of premature ejaculation;

    3. Able to complete questionnaires and scale scores independently. 2) control group

    4. 18-64 years old, regular sexual life > 6 months;

    5. Both partners are satisfied with their sexual life;

    6. Able to complete questionnaires and scale scores independently.

    Exclusion Criteria:
      1. case group

    1. Those who are unable to have sex due to genital malformation;

    2. Patients with serious cardiovascular and cerebrovascular diseases;

    3. Severe mental disorders (history of epilepsy, mania, etc.);

    4. Have a history of brain trauma;

    5. People with a long history of substance abuse. 2) control group

    6. Patients with a history of mental illness;

    7. Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants, triazolidine antidepressants, tramadol and sedatives

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Xijing Hospital, Fourth Military Medical University Xi'an Shaanxi China 710032

    Sponsors and Collaborators

    • Xijing Hospital
    • First Affiliated Hospital Xi'an Jiaotong University
    • Shaanxi Provincial People's Hospital
    • Xi'an No.3 Hospital
    • Shaanxi Armed Police Corps Hospital
    • Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Xijing Hospital
    ClinicalTrials.gov Identifier:
    NCT04235192
    Other Study ID Numbers:
    • 4222018004
    First Posted:
    Jan 21, 2020
    Last Update Posted:
    Jan 21, 2020
    Last Verified:
    Jan 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Xijing Hospital
    risk factor
    Additional relevant MeSH terms:
    Premature Birth
    Premature Ejaculation

    Study Results

    No Results Posted as of Jan 21, 2020